Xconomy | San Diego - Business + Technology in the Exponential Economy

people, VC, Life Sciences

Altair Therapeutics Changes CEO

Juha-Pekka Tikka 5/14/09

San Diego’s Altair Therapeutics today named former Forward Ventures partner Joel Martin as president and CEO. Martin, who left the San Diego life sciences VC firm in October, was previously a co-founder of Avant BioVentures. Altair’s current CEO Paul Brennan will continue working with the company. Privately held Altair, which was founded in 2007, develops therapeutics for respiratory diseases like asthma and rhinitis. Its first compound, an inhaled new class drug, is in Phase 1 clinical trials.


Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.